RHEUMATOID ARTHRITIS DIAGNOSTIC TESTS MARKET ANALYSIS

Rheumatoid Arthritis Diagnostic Tests Market,Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3716
Pages :165
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Regional Analysis

Global Rheumatoid Arthritis Diagnostic Tests Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global rheumatoid arthritis diagnostic tests market over the forecast period. North America is estimated to hold 39.45 % of the market share in 2023. The global rheumatoid arthritis diagnostic tests market is expected to witness significant growth in the coming years, Driven by the high prevalence of rheumatoid arthritis, favorable health reimbursement, and increased awareness, North America to emerge as the leading region for the rheumatoid arthritis diagnostic test market. According to the Centers for Disease Control and Prevention, the projected prevalence of the U.S. adults reported doctor-diagnosed arthritis report in 2020 seems to be 63 million. This region's rise can be related to a spike in arthritis in the U.S. and the rest of North America. For instance, according to the press release in February 2020, by imaware provides laboratory testing for wellness monitoring, informational, and educational use in North America., announced the launch of the At-Home Rheumatoid Arthritis Screening Test, designed by healthcare company Micro drop. The imaware test for Rheumatoid Arthritis uses just a few drops of blood to detect unique biomarkers as well as two additional biomarkers to provide more comprehensive results. These kinds of developments in the healthcare system and rising health expenditures, as well as increased knowledge of advanced rheumatoid arthritis treatments, are fueling the rheumatoid arthritis market in North America.

Rheumatoid Arthritis Diagnostic Tests Market Report Coverage

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa